NPC patients with elevated levels of CXCL10 have also been observed to have poorer prognosis (114), suggesting that despite their pro-inflammatory role, CXCL10 and IL-18 are unlikely to result in tumour-suppressive effects. This evidence concerns the gene IL18 and nasopharyngeal carcinoma.